Screener Summaries Updates Institutions Sign In More Updates › Financing › BJDX Financing · Jun 8, 2026
Bluejay Diagnostics, Inc. closed a private placement of pre-funded warrants, Series G warrants, and Series H warrants… BJDX Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. closed a private placement of pre-funded warrants, Series G warrants, and Series H warrants, receiving approximately $7.7 million in proceeds. The securities were sold at a combined price of $2.324 per warrant package.
More from Bluejay Diagnostics, Inc. Bluejay Diagnostics implements 1-for-4 reverse stock split effective November 3 Nov 4, 2026 Bluejay Diagnostics releases SYMON-II baseline data for Symphony IL-6 sepsis test Oct 6, 2026 Bluejay Diagnostics, Inc. entered into a Distribution, Co-Marketing & Strategic Partnership Agreement with Lovell… Sep 8, 2026 Bluejay Diagnostics reported Q2 2026 results, highlighting the completion of targeted enrollment for its SYMON-II… Aug 13, 2026 On July 21, 2026, Bluejay Diagnostics announced the completion of patient enrollment for its SYMON-II multicenter… Jul 22, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.